Andrea Anampa-Guzmán MD (She/Her)

Summary

• Dr. Andrea Anampa-Guzmán, MD is a Clinical Pharmacology Fellow at Mayo Clinic and an FDA–AACR Oncology Educational Fellow, with a focus on oncology drug development and translational pharmacology. Her work centers on applying quantitative approaches, including physiologically based pharmacokinetic (PBPK) modeling, to optimize dosing strategies and improve therapeutic outcomes in cancer patients.
  
  Dr. Anampa-Guzmán’s research spans clinical and translational oncology, with a particular emphasis on integrating pharmacology, patient-centered outcomes, and health equity. She has contributed to studies in lymphoma and survivorship and is committed to improving the representation of diverse populations in clinical trials and drug development.
  
  Originally from Peru, Dr. Anampa-Guzmán brings a global health perspective to her work, with a strong commitment to advancing equitable access to cancer care and innovative therapies. She is passionate about translating scientific discoveries into meaningful clinical and regulatory impact through multidisciplinary collaboration and data-driven decision-making.